WASHINGTON (US): US-based pharma company Moderna on Wednesday said that it expects its COVID-19 vaccine to be protective against the new mutated coronavirus reported in Britain.
“Moderna expects that the immunity induced by its COVID-19 vaccine would be protective against coronavirus variants reported in the United Kingdom (UK),” read the statement released by Moderna.
It also confirmed to perform additional tests of its vaccine in the coming weeks to check the effectiveness against the new strain of the virus.
Read More
- ADHD: An emerging discussion on a shared disorder
- Matcha Mania: Is the green drink really as healthy as it seems?
- Oman marks World Health Day, highlights commitment to health innovation and digital transformation
- Muscat oncology conference showcases latest advances in immunotherapy and targeted therapy
- Oman health authorities urge people to break fast if serious symptoms appear
“We plan to run tests to confirm the activity of the vaccine against any strain,” added the release.
Based on the data to date, Moderna expects that the vaccine-induced immunity from the Moderna COVID-19 vaccine would be protective against the variants of the SARS-CoV-2 virus recently discovered in the UK.
The forward-looking statements made by Moderna are based on current expectations and does not guarantee the success of the vaccine against the new mutated coronavirus. (ANI)
